insights_auto
Why is ARGX down 11.83%?
Dive Deeperchevron_right
ARGX:NASDAQ
argenx SE - ADR
$818.63
arrow_downward
-11.83%(-109.81) 1D
$819.80
arrow_upward
+0.14% (+1.17)bedtimeAfter hours
Closed: Oct 8, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$831.23
High
$832.24
Low
$787.73
Mkt. cap
52.35B
Avg. vol.
263.56K
Volume
2.45M
P/E ratio
31.10
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.89M
No. of employees
2K
Open
$831.23
High
$832.24
Low
$787.73
Mkt. cap
52.35B
Avg. vol.
263.56K
Volume
2.45M
P/E ratio
31.10
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
Benzinga
·
5 hours ago
$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today
Yahoo Finance
·
6 hours ago
ARGX Stock Sinks as Argenx Scraps Late-Stage Trial
PR Newswire
·
7 hours ago
argenx Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into argenx (ARGX)
Investor's Business Daily
·
7 hours ago
Former Highflying Biotech Hits The Skids On A Surprise Failure
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR